COVID-19 assay kit

IgGSARS-COV-2clinical

MDGen AB96-COVID-19 SP RBD IgG Kit is an Indirect Enzyme Linked Immunosorbent Assay (ELISA) intended for qualitative detection of Spike Protein Multi-Domain IgG antibodies to SARS-CoV-2 in human serum or plasma samples. MDGen AB96-COVID-19 SP RBD IgG employs synthetic peptides derived from the Spike(S) proteins of SARS-CoV-2 for the detection of IgG antibodies to SARS-CoV-2 in human serum or plasma. This kit is for in vitro diagnostic use only and intended as an aid to diagnose SARS-CoV-2 infection in patients with clinical symptoms and may be used to test whether a patient that has received the COVID-19 Vaccine has developed IgG antibodies. Product Feature ⊙ Does not require any complex, expansible or large machinery and is compatible with standard plate readers (450 nm) ⊙ May be used to test whether a vaccine recipient has developed IgG antibodies to SARS-CoV-2 through the vaccine ⊙ May also be used to determine whether the sample provider requires a booster shot ⊙ May be used to test all vaccines that include the SARS-CoV-2 Spike Protein ⊙ Not affected by variants as the product detects the whole Spike Protein (Both S1 and S2).